Figure 1
C/EBPs are involved in multiple innate immunity signaling pathways. C/EBPβ has been implicated in signaling pathways evoked
by several inflammatory stimuli, including LPS that binds to TLR4; cytokines acting via their respective receptors; bacterial
flagellin binding to TLR5; cAMP acting via G-coupled receptors and cigarette smoke as well as dsRNA and PNG that binds to
TLR3 and the Nod1 receptor present on intracellular endosomes. C/EBPs are activated via post-transcriptional modification
and hetero- or homodimerize. A number of enzymes have been demonstrated to activate C/EBPs by phosphorylating (p38, RSK, CaMKII,
and PKC) the transcription factors. Some post-transcriptional modifications, including phosphorylation by PKA and PKC, reduce
DNA-binding activity (enzymes indicated in red), and sumoylation leads to repression of COX2 transcription. Activated C/EBPβ
bind DNA and can induce transcription of pro-inflammatory genes. CaMII, Ca2+/calmodulin-dependent protein kinase; C/EBP, CCAAT/enhancer-binding protein; dsRNA, double-stranded RNA; IL, interleukin;
LPS, lipopolysaccharide; Nod, nucleotide-binding oligomerization domain-containing protein; PNG, peptidoglycan; PK, protein
kinase; RSK, ribosomal S6 kinase; SUMO, small ubiquitin-related modifier; TLR, Toll-like receptor.